Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure
- 1 February 1992
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 12 (2) , 187-191
- https://doi.org/10.1007/bf00172671
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intra-arterial cisplatin for the treatment of malignant gliomasJournal of Neuro-Oncology, 1989
- Intracarotid cisplatin chemotherapy for recurrent gliomasJournal of Neurosurgery, 1989
- Modalities of Cisplatin Administration to Brain TumorsCancer Investigation, 1989
- Topographic anatomy and CT correlations in the untreated glioblastoma multiformeJournal of Neurosurgery, 1988
- Visual system toxicity following intra‐arterial chemotherapyNeurology, 1988
- Phase II Trial of Intracarotid BCNU and Cisplatin in Primary Malignant Brain TumorsCancer Drug Delivery, 1986
- A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG studyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiformeJournal of Neurosurgery, 1983
- Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group studyJournal of Neuro-Oncology, 1983
- Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomasJournal of Neurosurgery, 1981